Chronic lymphocytic leukaemia vaccine - Vasogen

Drug Profile

Chronic lymphocytic leukaemia vaccine - Vasogen

Alternative Names: CLL vaccine - Vasogen; Immune modulation therapy-chronic lymphocytic leukaemia - Vasogen

Latest Information Update: 23 Mar 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Vasogen
  • Class Cancer vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Chronic lymphocytic leukaemia

Most Recent Events

  • 23 Mar 2007 Discontinued - Phase-I for Chronic lymphocytic leukaemia in Canada (unspecified route)
  • 15 Sep 2003 A study has been added to the Cancer therapeutic trials section
  • 04 Jul 2001 Phase-I clinical trials for Chronic lymphocytic leukaemia in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top